1. Rosen Law Firm investigates Encompass Health for misleading business information. 2. Investors may join a class action lawsuit for potential compensation. 3. Encompass Health's stock fell 10.3% following negative media coverage. 4. The firm's investigation stems from patient safety allegations. 5. Shareholders could be entitled to losses without upfront fees.
The allegations of misleading information and subsequent price drop suggest negative investor sentiment.
Legal actions can significantly affect stock prices; recent falls highlight investors' concerns.
Immediate impact due to ongoing legal issues can drive volatility in the stock.
NEW YORK, Aug. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE:EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public.
So what: If you purchased Encompass Health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=44051 https://rosenlegal.com/submit-form/?case_id=41168or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
What is this about: On July 15, 2025, The New York Times published an article entitled "Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed." The article stated that "[r]ehab hospitals that help people recover from major surgeries and injuries have become a highly lucrative slice of the health care business. But federal data and inspection reports show that some run by the dominant company, Encompass Health Corporation, [. . .] have had rare but serious incidents of patient harm and perform below average on two key safety measures tracked by Medicare."
On this news, the price of Encompass Health stock fell 10.3% on July 15, 2025.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ehc-investors-have-opportunity-to-lead-encompass-health-corporation-securities-fraud-lawsuit-302542390.html
SOURCE THE ROSEN LAW FIRM, P. A.